🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Softgel(s) Serving Size
60 Servings
Fat/Fatty Acid Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Calories
5 Calorie(s)
Total Fat
0.5 Gram(s) (1% DV)
📊 Market median: 100.0mg (108 products)
Median 100.0mg This product: 500mg

Other Ingredients

Bovine Gelatin Glycerin Water, Purified Sorbitol

Label Claims — Verification

Nutrient
All Other
Structure/Function

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free Sugar Free

Product Information

📋 Directions for Use

Directions: As a dietary supplement, take one softgel daily or as directed by a healthcare practitioner.

⚠️ Warnings & Precautions

Caution: For adults only.

Consult physician if pregnant/nursing, taking medication, or have a medical condition.

Keep out of reach of children.

Contains: Soybeans

🧪 Formulation Notes

Bluebonnet's Phosphatidylserine 100 mg softgels are formulated with patented phosphatidylserine (PS), Sharp PS derived from soybeans that delivers 100 mg of PS per serving to support brain health, memory, and cognitive function.

Free of milk, egg, fish, crustacean shellfish, tree nuts, peanuts, wheat and sesame. Also free of gluten, barley, rice, sodium and sugar.

Made in USA from domestic and imported ingredients.

Brain Health

Sharp-PS

Gluten Free

Additional Information

Store tightly closed in a cool, dry place.

Product Details

UPC / SKU 7 43715 00940 0
DSLD Entry Date 2024-07-25
Product Type Fat/Fatty Acid
Form Softgel Capsule
Brand Bluebonnet
DSLD ID 316453
Data Updated 2026-04-11

Research Evidence

We're building the evidence profile for this product's ingredients.

Our team is working to connect every product on the American market with peer-reviewed research. Check back soon for evidence-backed analysis.